Literature DB >> 8613424

Second primary neoplasms in thyroid cancer patients.

K Ishikawa1, S Noguchi, K Tanaka, A Fukuda, T Hirohata.   

Abstract

To determine risk patterns for second primary neoplasms after the occurrence of thyroid cancer, we conducted a retrospective cohort study of 3321 thyroid cancer patients who were operated and histologically confirmed at the Noguchi Thyroid Clinic and Hospital Foundation between 1946 and 1985. They were followed from the date of operation through the end of 1990 with an observation period from 45 to 5 years. The average observation period of the patients was 13.4 years and the follow-up rate reached 98%. The standardized mortality ratio (SMR) was computed to assess possible risk increase by cancer site. In this computation, the time period less than 5 years after operation was omitted to reduce the influence of deaths related to the original thyroid cancer. A total of 103 deaths from malignant neoplasms other than thyroid cancer were observed during this time period (SMR = 1.6, 95% confidence interval [CI] = 1.3-2.0). Analyses of site-specific cancer mortality revealed significantly elevated risks for the central nervous system (SMR = 16.1, CI = 5.2-37.6) and respiratory organs (SMR = 2.6, CI = 1.5-4.1). Based on a review of available medical records with histological findings, we concluded that the risk increases for these sites were most likely to be attributable to second primary neoplasms. Whether or not the patients had received radiotherapy was not significantly associated with elevated risk. Further investigations are needed to clarify the risk factors responsible for the above findings.

Entities:  

Mesh:

Year:  1996        PMID: 8613424      PMCID: PMC5921095          DOI: 10.1111/j.1349-7006.1996.tb00211.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  48 in total

1.  Accuracy of cause-of-death certification in Hiroshima and Nagasaki, Japan.

Authors:  S Jablon; D Thompson; M McConney; K Mabuchi
Journal:  Ann N Y Acad Sci       Date:  1990       Impact factor: 5.691

2.  Second primary tumors following thyroid cancer. A Swedish record-linkage study.

Authors:  P Hall; L E Holm; G Lundell
Journal:  Acta Oncol       Date:  1990       Impact factor: 4.089

3.  Subsequent malignancies in patients treated with 131-iodine for thyroid cancer.

Authors:  C Glanzmann
Journal:  Strahlenther Onkol       Date:  1992-06       Impact factor: 3.621

4.  Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group.

Authors:  L E Rutqvist; H Johansson; T Signomklao; U Johansson; T Fornander; N Wilking
Journal:  J Natl Cancer Inst       Date:  1995-05-03       Impact factor: 13.506

5.  Does the method of management of papillary thyroid carcinoma make a difference in outcome?

Authors:  L J DeGroot; E L Kaplan; F H Straus; M S Shukla
Journal:  World J Surg       Date:  1994 Jan-Feb       Impact factor: 3.352

6.  A population-based case-control study of thyroid cancer.

Authors:  E Ron; R A Kleinerman; J D Boice; V A LiVolsi; J T Flannery; J F Fraumeni
Journal:  J Natl Cancer Inst       Date:  1987-07       Impact factor: 13.506

7.  Thyroid cancer after radiotherapy for skin hemangioma in infancy.

Authors:  M Lundell; T Hakulinen; L E Holm
Journal:  Radiat Res       Date:  1994-12       Impact factor: 2.841

8.  Reproductive factors and risk of brain, colon, and other malignancies in Iowa (United States).

Authors:  K P Cantor; C F Lynch; D Johnson
Journal:  Cancer Causes Control       Date:  1993-11       Impact factor: 2.506

9.  Risk of subsequent malignant neoplasms among 470,000 cancer patients in Finland, 1953-1991.

Authors:  R Sankila; E Pukkala; L Teppo
Journal:  Int J Cancer       Date:  1995-02-08       Impact factor: 7.396

10.  p53 gene mutations associated with anaplastic transformation of human thyroid carcinomas.

Authors:  T Nakamura; I Yana; T Kobayashi; E Shin; K Karakawa; S Fujita; A Miya; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-12
View more
  1 in total

1.  Second primary malignancies in thyroid cancer patients.

Authors:  C Rubino; F de Vathaire; M E Dottorini; P Hall; C Schvartz; J E Couette; M G Dondon; M T Abbas; C Langlois; M Schlumberger
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.